Kroger Bears Dig In With Earnings One Day Away
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

Three separate ORTEX signals have converged on KR in the 72 hours before its September 15 earnings print. Short interest, options positioning, and borrowing costs are all moving in the same direction. The setup has grown more pronounced since the trader note published Thursday.
Shorts Extended, Not Retreating
Short interest now stands at 4.55% of the free float. That's up 15.2% over the past week and marks the highest level since early August. The build is not a single-day anomaly. Shorts added roughly 2.9 million shares in one session on September 10, then added again the following day. The week-long accumulation has pushed the position to ~30.2 million shares — essentially back to where it was at the August peak before a mid-month retreat.
The borrow market, however, remains untroubled. Availability sits at 860% — more than eight shares available to lend for every one currently borrowed. Cost to borrow is 0.57%, up 54% on the week. That's a notable move in percentage terms, but the absolute level remains firmly in easy-borrow territory. There is no squeeze pressure here. Short sellers are building positions, not being squeezed out of them.
Options Markets Price in Downside
The put/call ratio reached 0.786 on September 11. That's 2.14 standard deviations above the 20-day mean of 0.69 — the most defensive options tilt since late August. The 52-week peak is 0.84, so the current reading is elevated but not extreme. What matters is the direction. The PCR was below 0.65 as recently as the final days of August. Options traders have rotated toward downside protection sharply and quickly.
Both signals now point the same way: shorts are adding exposure, and options buyers are paying more for puts than at almost any point this year.
What the Street Says
Analyst opinion provides important context. Citigroup's Paul Lejuez cut his target to $57 on September 1 — below the current price of $58.49 — while maintaining a Neutral rating. Evercore ISI retains an Outperform but has trimmed its target twice since July, arriving at $75. The consensus mean sits at $68.45. That gap between the consensus and the two most cautious targets near spot price reflects a genuine split on the Street.
The bull case centres on Giant Eagle synergies and a sharp forward EPS upgrade cycle — the eps_12m_fwd_yoy_increase factor score ranks in the 80th percentile. The bear case is simpler: food volumes have weakened in absolute terms even as market share held, and pricing pressure from competitors has yet to ease.
Berkshire Hathaway trimmed 11 million shares as of June 30, the most significant institutional move among top holders.
What to Watch
Earnings land September 15. The alignment of rising short interest, elevated put/call ratios, and increasing borrowing costs going into the print means any negative surprise has more force behind it than the headline short interest figure alone would suggest.
Data summary
- SI % of free float: 4.55%, up 15.2% on the week
- Short shares: ~30.2 million
- Cost to borrow: 0.57%, up 54% on the week
- Borrow availability: 860% (ample)
- Put/call ratio: 0.786, z-score +2.14
- Consensus price target: $68.45 vs. $58.49 spot
- Earnings: September 15, 13:30 UTC
Against its own history
This week's change in short interest is 2.4 standard deviations above the company's typical weekly move over the past year.
Against its peers
Shares moved -0.2% over the past week against a median of -1.5% for its closest peers.
Stocks in this article
See the live data behind this article on ORTEX.
Open KR on ORTEX →How this article was generated
- Generated
- 14 Sept 2026, 11:16
- Data as of
- 14 Sept 2026, 11:07
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.